JAMDA
July 2, 2026
Showing 1 - 10 of 118 results
JAMDA
April 19, 2026
Reasons Behind Continuity of In-Hospital Deprescribing Post Discharge: A Qualitative Study
Deprescribing reduces inappropriate polypharmacy in older adults and may be initiated in hospital. However, deprescribing changes initiated during a hospital admission are not always continued post discharge and deprescribing recommendations for inpatients to implement post discharge are not always actione...
JAMDA
January 7, 2026
Nutritional and Pharmacological Interventions for Sarcopenia in Older Adults: A Systematic Review and Network Meta-Analysis
This study aimed to compare the impacts of different nutritional supplements and drugs on older adults with sarcopenia.
JAMDA
December 15, 2025
Development of a Model to Predict the Risk of Chronic Opioid Use After Entry Into Long-Term Care Facilities
Chronic opioid use is common in residents of long-term care facilities (LTCFs) and is associated with an increased risk of falls, fractures, and cognitive impairment. However, predictors of chronic opioid use in this cohort remain unclear. This study developed a prediction model for new chronic opioid use ...
JAMDA
December 5, 2025
Factors Associated With 1-Year Home Health Admission Among Older Adults Initiating Long-Term Opioid Therapy
Long-term opioid therapy (LTOT) in older adults poses risks of cognitive and functional decline. This study aimed to identify factors associated with home health admission within 1 year of LTOT initiation among Medicare-enrolled older adults.
JAMDA
August 5, 2025
Potentially High-Risk Antipsychotic Use in People With Dementia: A National Data Linkage Study
To investigate the prevalence of and sociodemographic factors associated with potentially high-risk antipsychotic use in people living with dementia in Australia.
JAMDA
July 10, 2025
Usage and Costs of Regular Acetaminophen (Paracetamol) in Canadian Long-Term Care Facilities
Evidence suggests that the use of regular acetaminophen (paracetamol) in long-term care (LTC) is a low-value intervention, that it does not improve pain or quality of life, and that it has the potential for adverse effects. Our objective was to assess the usage of regular acetaminophen in Canadian LTC faci...
JAMDA
June 14, 2025
Central Nervous System Polypharmacy Among People Living With Dementia
The Centers for Medicare and Medicaid Services Polypharmacy-CNS (Poly-CNS) quality metric identifies individuals taking multiple medications with central nervous system side effects. The Poly-CNS measure may reduce risky prescribing for persons living with dementia (PLWD).
JAMDA
April 13, 2025
Agreement of Medicare Part D and Minimum Data Set Reported Psychotropic Medication Use in Nursing Homes
Little evidence exists on the accuracy of the Minimum Data Set (MDS)–based medication items. We compared quarterly rates of antipsychotic, antidepressant, and hypnotic use between the MDS and Part D Prescription Drug Event file (PDE) in 2018.
JAMDA
March 21, 2025
High Anticholinergic Burden of Patients Hospitalized for Hip Fracture Reveals a Target for Deprescribing
Anticholinergic medications can produce harmful side effects, such as ataxia and delirium, in older adults. Older adults with hip fractures are particularly vulnerable, yet they are often prescribed these medications. This study aimed to evaluate the anticholinergic burden (ACB) before and after hospitaliz...
